VSNL1 and Alzheimer disease: Eligible studies reporting VILIP-1 concentrations in CSF included 11 cohorts of patients with AD (n = 595) and CTRL (n = 893), and gave an average ratio of 1.34, 95% CI (1.28 to 1.41), z = 11.69, p < 0.001 (Figure 3A) (Supplementary Figure S25, Supplementary Table S3 (7.A)).